Despite the differences described above, results were fairly similar, with HRs of around 0.80 (range 0.79 to 0.88) and of borderline significance at the 5% level (Fig. 3 a).
← all excerpts
Duplicated network meta-analysis in advanced prostate cancer: a case study and recommendations for change.
1
—
—